相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
Etsuro Ohta et al.
FEBS LETTERS (2011)
Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
Diane Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibition of Cyclin-Dependent Kinase 5 but Not of Glycogen Synthase Kinase 3-β Prevents Neurite Retraction and Tau Hyperphosphorylation Caused by Secretable Products of Human T-Cell Leukemia Virus Type I-Infected Lymphocytes
Horacio Maldonado et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
A QUICK Screen for Lrrk2 Interaction Partners - Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
Andrea Meixner et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis
Etsuro Ohta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
Tatsunori Maekawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation
Makoto Kubo et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Unraveling LRRK2 Pathogenesis: Common Pathways for Complex Genes?
Emma Deas et al.
JOURNAL OF NEUROSCIENCE (2010)
LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3β
Chin-Hsien Lin et al.
JOURNAL OF NEUROSCIENCE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity
Susanne Zach et al.
PLOS ONE (2010)
Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wild-type molecule
Etsuro Ohta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
Saskia Biskup et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: An in vitro model of HTLV-I-induced disease
HORACIO MALDONADO et al.
BIOLOGICAL RESEARCH (2009)
LRRK2 in Parkinson's disease: function in cells and neurodegeneration
Philip J. Webber et al.
FEBS JOURNAL (2009)
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
Frank Gillardon
JOURNAL OF NEUROCHEMISTRY (2009)
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro
Christian Johannes Gloeckner et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
A novel consensus phosphorylation motif in sulfatide- and cholesterol-3-sulfate-binding protein substrates for CK1 in vitro
Fumitaka Kawakami et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3β and the GSK-3β-mediated phosphorylation of myelin basic protein in vitro
Fumitaka Kawakami et al.
JOURNAL OF BIOCHEMISTRY (2008)
The roles of kinases in familial Parkinson's disease
Mark R. Cookson et al.
JOURNAL OF NEUROSCIENCE (2007)
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation
Judith Miklossy et al.
ACTA NEUROPATHOLOGICA (2007)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Ciro Iaccarino et al.
HUMAN MOLECULAR GENETICS (2007)
Identification of potential protein interactors of Lrrk2
Justus C. Daechsel et al.
PARKINSONISM & RELATED DISORDERS (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
LRRK2 expression in normal and pathologic human brain and in human cell lines
Judith Miklossy et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
分享论文
